193 related articles for article (PubMed ID: 16268755)
1. The effects of prescription drug cost sharing: a review of the evidence.
Gibson TB; Ozminkowski RJ; Goetzel RZ
Am J Manag Care; 2005 Nov; 11(11):730-40. PubMed ID: 16268755
[TBL] [Abstract][Full Text] [Related]
2. Effect of tiered prescription copayments on the use of preferred brand medications.
Rector TS; Finch MD; Danzon PM; Pauly MV; Manda BS
Med Care; 2003 Mar; 41(3):398-406. PubMed ID: 12618643
[TBL] [Abstract][Full Text] [Related]
3. Impact of statin copayments on adherence and medical care utilization and expenditures.
Gibson TB; Mark TL; Axelsen K; Baser O; Rublee DA; McGuigan KA
Am J Manag Care; 2006 Dec; 12 Spec no.():SP11-9. PubMed ID: 17173486
[TBL] [Abstract][Full Text] [Related]
4. Changes in drug utilization following the outpatient prescription drug cost-sharing program--evidence from Taiwan's elderly.
Liu SZ; Romeis JC
Health Policy; 2004 Jun; 68(3):277-87. PubMed ID: 15113639
[TBL] [Abstract][Full Text] [Related]
5. Cost-sharing effects on adherence and persistence for second-generation antipsychotics in commercially insured patients.
Gibson TB; Jing Y; Kim E; Bagalman E; Wang S; Whitehead R; Tran QV; Doshi JA
Manag Care; 2010 Aug; 19(8):40-7. PubMed ID: 20822071
[TBL] [Abstract][Full Text] [Related]
6. A conceptually based approach to understanding chronically ill patients' responses to medication cost pressures.
Piette JD; Heisler M; Horne R; Caleb Alexander G
Soc Sci Med; 2006 Feb; 62(4):846-57. PubMed ID: 16095789
[TBL] [Abstract][Full Text] [Related]
7. Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma.
Dormuth CR; Glynn RJ; Neumann P; Maclure M; Brookhart AM; Schneeweiss S
Clin Ther; 2006 Jun; 28(6):964-78; discussion 962-3. PubMed ID: 16860179
[TBL] [Abstract][Full Text] [Related]
8. Do consumers' attitudes predict prescription purchasing behavior?
Nair KV
Manag Care Interface; 2003 Jun; 16(6):22-7, 55. PubMed ID: 12841073
[TBL] [Abstract][Full Text] [Related]
9. The impact of cost sharing of prescription drug expenditures on health care utilization by the elderly: own- and cross-price elasticities.
Li X; Guh D; Lacaille D; Esdaile J; Anis AH
Health Policy; 2007 Aug; 82(3):340-7. PubMed ID: 17134787
[TBL] [Abstract][Full Text] [Related]
10. Controlling prescription drug expenditures: a report of success.
Miller DP; Furberg CD; Small RH; Millman FM; Ambrosius WT; Harshbarger JS; Ohl CA
Am J Manag Care; 2007 Aug; 13(8):473-80. PubMed ID: 17685828
[TBL] [Abstract][Full Text] [Related]
11. Incentive formularies and changes in prescription drug spending.
Landon BE; Rosenthal MB; Normand SL; Spettell C; Lessler A; Underwood HR; Newhouse JP
Am J Manag Care; 2007 Jun; 13(6 Pt 2):360-9. PubMed ID: 17567237
[TBL] [Abstract][Full Text] [Related]
12. Impact of 3-tier pharmacy benefit design and increased consumer cost-sharing on drug utilization.
Landsman PB; Yu W; Liu X; Teutsch SM; Berger ML
Am J Manag Care; 2005 Oct; 11(10):621-8. PubMed ID: 16232003
[TBL] [Abstract][Full Text] [Related]
13. A comparison of mail-service and retail community pharmacy claims in 5 prescription benefit plans.
Clark BE; Siracuse MV; Garis RI
Res Social Adm Pharm; 2009 Jun; 5(2):133-42. PubMed ID: 19524861
[TBL] [Abstract][Full Text] [Related]
14. The implications of choice: prescribing generic or preferred pharmaceuticals improves medication adherence for chronic conditions.
Shrank WH; Hoang T; Ettner SL; Glassman PA; Nair K; DeLapp D; Dirstine J; Avorn J; Asch SM
Arch Intern Med; 2006 Feb; 166(3):332-7. PubMed ID: 16476874
[TBL] [Abstract][Full Text] [Related]
15. The impact of cost-sharing on appropriate utilization and health status: a review of the literature on seniors.
Rice T; Matsuoka KY
Med Care Res Rev; 2004 Dec; 61(4):415-52. PubMed ID: 15536208
[TBL] [Abstract][Full Text] [Related]
16. Effect of copayments on drug use in the presence of annual payment limits.
Kephart G; Skedgel C; Sketris I; Grootendorst P; Hoar J
Am J Manag Care; 2007 Jun; 13(6 Pt 2):328-34. PubMed ID: 17567233
[TBL] [Abstract][Full Text] [Related]
17. The effects of prescription drug copayments on statin adherence.
Gibson TB; Mark TL; McGuigan KA; Axelsen K; Wang S
Am J Manag Care; 2006 Sep; 12(9):509-17. PubMed ID: 16961440
[TBL] [Abstract][Full Text] [Related]
18. Review and analysis of hospitalization costs associated with antipsychotic nonadherence in the treatment of schizophrenia in the United States.
Sun SX; Liu GG; Christensen DB; Fu AZ
Curr Med Res Opin; 2007 Oct; 23(10):2305-12. PubMed ID: 17697454
[TBL] [Abstract][Full Text] [Related]
19. Impact of a Medicaid copayment policy on prescription drug and health services utilization in a fee-for-service Medicaid population.
Hartung DM; Carlson MJ; Kraemer DF; Haxby DG; Ketchum KL; Greenlick MR
Med Care; 2008 Jun; 46(6):565-72. PubMed ID: 18520310
[TBL] [Abstract][Full Text] [Related]
20. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use.
Hansen RA; Schommer JC; Cline RR; Hadsall RS; Schondelmeyer SW; Nyman JA
Res Social Adm Pharm; 2005 Jun; 1(2):139-57. PubMed ID: 17138472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
